Communication
Organic & Biomolecular Chemistry
11 T. Lemster, U. Pindur, G. Lenglet, S. Depauw, C. Dassi and 25 T. P. Smyth and B. W. Corby, J. Org. Chem., 1998, 63, 8946.
M. D. Cordonnier, Eur. J. Med. Chem., 2009, 44, 3235.
12 M. Laronze, M. Boisburn, S. Leonce, B. Pfeiffer, P. Renard,
O. Lozach, L. Meijer, A. Lansiuax and C. Bailly, Bioorg. Med.
Chem., 2005, 13, 2263.
13 M. Stiborova, M. Rupertova, D. Aimova, H. Ryslava and
E. Feri, Toxicology, 2007, 236, 50.
14 S. Baroniya, Z. Anwer, P. K. Sharma, R. Dudhe and
N. Kumar, Der Pharmacia Sinica, 2010, 1, 172.
15 S. Routier, P. Peixoto, J. Y. Merour, G. Coudert, N. Dias,
C. Bailly and A. Pierre, J. Med. Chem., 2006, 49, 789.
16 H. Kaur, S. Kumar, P. Vishwakarma, M. Sharma, K. K. Saxena
and A. Kumar, Eur. J. Med. Chem., 2010, 45, 2777.
26 (a) S. G. P. Plant and M. L. Tomlinson, J. Chem. Soc., 1932,
2188; (b) M. Chakrabarty, N. Ghosh, S. Khasnobis and
M. Chakrabarty, Synth. Commun., 2002, 32, 265;
(c) L. Ackermann and A. Althammer, Angew. Chem., Int. Ed.,
2007, 46, 1627.
27 (a) L. V. Rubinstein, R. H. Shoemaker, K. D. Paull,
R. M. Simon, S. Tosini, P. Skehan, D. A. Scudiero, A. Monks
and M. R. Boyd, J. Natl. Cancer Inst., 1990, 82, 1113;
(b) P. Skehan, R. Storeng, D. Scudiero, A. Monks,
J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney
and M. R. Boyd, J. Natl. Cancer Inst., 1990, 82, 1107.
28 E. Chu and V. T. DeVita, Physicians’ Cancer Chemotherapy
Drug Manual, 2007, Jones & Bartlett, 2007.
29 Gemcitabine, generally used in various carcinomas such as
non-small cell lung cancer, pancreatic cancer, bladder
cancer and breast cancer, has shown in vitro GI50 value of
0.14 µM in the Human Tumor Cell Line Assay (NCI-60) and
was validated; see: W. Wu, J. Sigmond, G. J. Peters and
R. F. Borch, J. Med. Chem., 2007, 50, 3743.
17 J. Bouchard, S. Wakim and M. Leclerc, J. Org. Chem., 2004,
69, 5705.
18 G. Zhu, S. E. Corner, X. Zhou, H. K. Chan, C. Shih,
T. A. Engler, S. A. Watkins, C. D. Spencer, R. M. Schultz
and J. A. Dempsey, Bioorg. Med. Chem. Lett., 2004, 14, 3057.
19 E. Conchon, F. Anizon, B. Aboab, M. Golsteyn, S. Leonce
and B. Pfeiffer, Eur. J. Med. Chem., 2008, 43, 282.
20 R. Kumar, U. Ramachandran, K. Srinivasan, P. Ramarao, 30 (a) Compounds 3a, 3d, 3g, 3h and 3n showed >100% inhi-
S. Raichur and R. Chakrabarti, Bioorg. Med. Chem., 2005,
13, 4279.
bition of CAL 27 cells at 10 µM. The %inhibition more
than 100% is considered as an indication of complete inhi-
bition; see for example: Y. Hikichi, K. Honda, K. Hikami,
H. Miyashita, I. Kaieda, S. Murai, N. Uchiyama,
M. Hasegawa, T. Kawamoto, T. Sato, T. Ichikawa, S. Cao,
Z. Nie, L. Zhang, J. Yang, K. Kuida and E. Kupperman, Mol.
Cancer Ther., 2012, 11, 700. The possible reason for such
observation is that the cells were not only inhibited but
also were killed to some extent by these compounds. We
thank one of the reviewers for pointing out this. (b) The
dose in these curves is represented using a semi-logarith-
mic plot. On a semi-logarithmic plot, the amount of drug
is plotted (on the X axis) as the log of drug concentration
and response is plotted (on the Y axis) using a linear scale.
For representative examples, see: A. Kumar, M. Zhang,
L. Zhu, R. P. Liao, C. Mutai, S. Hafsat, D. R. Sherman and
M.-W. Wang, PLoS One, 2012, 7, e39961, DOI: 10.1371/
journal.pone.0039961.
21 (a) G. J. Atwell, W. A. Denny and M. Tercel, Condensed
N-aclyindoles as antitumor agents, WO 1998011101 A3,
April 23, 1998; (b) H. Takayama, Y. Yaegashi, M. Kitajima,
X. Han, K. Nishimura, S. Okuyama and K. Igarashi, Bioorg.
Med. Chem. Lett., 2007, 17, 4729.
22 (a) W. C. Sumpter and F. M. Miller, The chemistry of hetero-
cyclic compounds, indole and carbazole systems, John Wiley &
Sons, 2009, pp. 104–105; (b) N. Naik, H. V. Kumar and
H. Swetha, Bulg. Chem. Commun., 2010, 42, 40.
23 (a) S. Pal, M. A. Khan, P. Bindu and P. K. Dubey, Beilstein
J. Org. Chem., 2007, 3, DOI: 10.1186/1860-5397-3-35;
(b) S. Pal, P. Bindu, P. R. Venna and P. K. Dubey, Lett. Org.
Chem., 2007, 4, 292; (c) C. Galli, Synthesis, 1979, 303;
(d) T. P. Smyth and B. W. Corby, Org. Process Res. Dev.,
1997, 1, 264; (e) V. R. Veeramaneni, K. R. Yeleswarapu and
M. Pal, Tetrahedron, 2003, 59, 3283.
3493.
facts/.
6084 | Org. Biomol. Chem., 2014, 12, 6080–6084
This journal is © The Royal Society of Chemistry 2014